2 Beaten-Down Stocks With Massive Upside Potential
There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (NASDAQ: CRSP) and Viking Therapeutics (NASDAQ: VKTX), two mid-cap biotech companies that have lagged broader equities over the trailing-12-month period.
Even with these poor performances, however, there are solid reasons to consider investing in these stocks, especially at current levels. Read on to find out more.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€24.08
1.180%
Our community is currently high on Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 45 € there is a hugely positive potential of 86.92% for Viking Therapeutics Inc compared to the current price of 24.08 €.
